Camila Coelho

Dr. Camila Coelho, a Principal Investigator at the Icahn School of Medicine, dives into her lab's work on emerging pathogens like mpox. She discusses the complexities of orthopox vaccines, including the safety versus efficacy trade-offs of various smallpox vaccines. Camila shares insights on antibody discovery, emphasizing the evolution of methods to map neutralizing epitopes. Moreover, she highlights her commitment to mentorship in science and how her MBA helps enhance her lab leadership and team dynamics.